Piperacillin-tazobactam desensitisation

被引：0
|
作者：
Sanchez Ramos, I [1 ]
Puente Crespo, Y. [1 ]
Daza Munoz, J. [1 ]
Guardia Martinez, P. [1 ]
Conde Hernandez, J. [1 ]
机构：
[1] Virgen Macarena Univ Hosp, Seville, Spain
来源：
ALLERGY | 2008年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
626
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [31] Assessment of biliary excretion of piperacillin-tazobactam in humans
    Westphal, JF
    Brogard, JM
    CaroSampara, F
    Adloff, M
    Blickle, JF
    Monteil, H
    Jehl, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1636 - 1640
  • [32] The use of piperacillin-tazobactam in neonatal and paediatric patients
    Wolf, Maria F.
    Simon, Arne
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (01) : 57 - 69
  • [33] False positive galactomannan Platelia due to piperacillin-tazobactam
    Gerlinger, M. P.
    Rousselot, P.
    Rigaudeau, S.
    Billon, C.
    Touratier, S.
    Castaigne, S.
    Eloy, O.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (01): : 10 - 14
  • [34] Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy
    Wong, Jane C. Y.
    Au, Elaine Y. L.
    Yeung, Heather H. F.
    Lau, Chak-Sing
    Li, Philip Hei
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (02) : 284 - 294
  • [35] Piperacillin-Tazobactam: Extended Infusion Versus Continuous Infusion
    Messori, Andrea
    Tulli, Giorgio
    Caccese, Erminia
    Trippoli, Sabrina
    Marinai, Claudio
    CRITICAL CARE MEDICINE, 2018, 46 (07) : E725 - E725
  • [36] Detection of galactomannan content in generic piperacillin-tazobactam products
    Saez de la Fuente, Javier
    Campelo-Gutierrez, Carolina
    Izquierdo-Garcia, Elsa
    Esteban, Aznar
    Jose Manuel, Caro
    Gimenez-Manzorro, Alvaro
    Garcia Diaz, Benito
    Becares, Javier
    INFECTIOUS DISEASES, 2019, 51 (02) : 157 - 159
  • [37] Pharmacoeconomic analysis of extended-infusion piperacillin-tazobactam
    Raja, Karan
    Patel, Ruben
    Patel, Mitesh
    Attalla, Mark
    Philips, Mona
    PHARMACOTHERAPY, 2017, 37 (12): : E126 - E126
  • [38] Piperacillin-tazobactam concentration target attainment in children with cancer
    Saffioti, Carolina
    Mesini, Alessio
    Barco, Sebastiano
    Cangemi, Giuliana
    Bandettini, Roberto
    Castagnola, Elio
    PEDIATRIC BLOOD & CANCER, 2019, 66 (10)
  • [39] Galactomannan in piperacillin-tazobactam: How much and to what extent?
    Machetti, M
    Furfaro, E
    Viscoli, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) : 3984 - 3985
  • [40] Piperacillin-Tazobactam: An Unlikely Distractor In Invasive Aspergillosus Testing
    Dziamski, K. M.
    Gupta, K.
    Chandrasekar, V. Thoguluva
    Zaidi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345